NEA Management Company, LLC
CIK 0001512848 · TIMONIUM, MD · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$1.59B
2026 Q2
Positions
26
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
89.8%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
TRVI
Trevi Therapeutics, Inc.
15.5%
MBX
MBX Biosciences, Inc.
12.6%
GLUE
Monte Rosa Therapeutics, Inc.
11.7%
CELC
Celcuity Inc.
11.3%
SGP
Spyglass Pharma, Inc.
10.4%
SVRA
Savara, Inc.
9.5%
ZBIO
Zenas BioPharma, Inc.
6.4%
COUR
Coursera, Inc.
4.6%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.